Application of Radiomics in Prognosing Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Lung cancer is one of the most common cancers and can be difficult to treat. One of the treatment methods uses drugs that target a protein called the epidermal growth factor receptor, but the results vary from patient to patient. In this research, we used a technique called radiomics...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting-Wei, Hsu, Ming-Sheng, Lin, Yi-Hui, Chiu, Hwa-Yen, Chao, Heng-Sheng, Liao, Chien-Yi, Lu, Chia-Feng, Wu, Yu-Te, Huang, Jing-Wen, Chen, Yuh-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377421/
https://www.ncbi.nlm.nih.gov/pubmed/37509204
http://dx.doi.org/10.3390/cancers15143542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377421/
https://www.ncbi.nlm.nih.gov/pubmed/37509204
http://dx.doi.org/10.3390/cancers15143542

Ejemplares similares